CVA Family Office’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8K Sell
156
-116
-43% -$19.3K ﹤0.01% 772
2026
Q1
$57.1K Buy
272
+23
+9% +$5.78K 0.01% 569
2025
Q4
$70.8K Hold
249
0.01% 495
2025
Q3
$76.9K Buy
249
+2
+0.8% +$627 0.01% 467
2025
Q2
$77.6K Hold
247
0.01% 457
2025
Q1
$64.9K Buy
247
+2
+0.8% +$541 0.01% 476
2024
Q4
$64K Hold
245
0.01% 472
2024
Q3
$57K Sell
245
-5
-2% -$1.03K 0.01% 484
2024
Q2
$50.5K Buy
250
+145
+138% +$26.1K 0.01% 496
2024
Q1
$18K Hold
105
﹤0.01% 663
2023
Q4
$22.8K Buy
+105
New +$18K ﹤0.01% 603
2023
Q3
Sell
-30
Closed -$8.65K 759
2023
Q2
$8.65K Hold
30
﹤0.01% 739
2023
Q1
$9.57K Hold
30
﹤0.01% 697
2022
Q4
$8.83K Hold
30
﹤0.01% 674
2022
Q3
$7K Sell
30
-10
-25% -$2.5K ﹤0.01% 680
2022
Q2
$9K Buy
+40
New +$9.09K ﹤0.01% 662
2021
Q3
Sell
-5
Closed -$1K 752
2021
Q2
$1K Buy
+5
New +$1.36K ﹤0.01% 922

Other funds holding PODD

CVA Family Office's PODD Position: Q2 2026 in Review

CVA Family Office reduced its Insulet (PODD) stake by 43% in Q2 2026, selling an estimated $19.3K and leaving 156 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #772.

CVA Family Office first reported a position in PODD in Q2 2021 and has held it in 17 quarters since. The position peaked at $77.6K in Q2 2025. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • CVA Family Office held 156 shares of Insulet worth $23.8K as of Q2 2026.
  • CVA Family Office sold 116 Insulet shares in Q2 2026, an estimated $19.3K.
  • Insulet made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #772 holding.
  • CVA Family Office first reported a position in Insulet in Q2 2021 and has held it in 17 quarters since.
  • CVA Family Office's Insulet position peaked at $77.6K in Q2 2025.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.